EVE Health Group advised that Mr. James Lin has retired from the Company's board. Mr. Lin joined the Company's board in April 2021 as a nominee director of Hong Kong Jusheng Bolang Technology Co., Limited ("Jusheng Bolang"). Following the completion of the Company's recent Entitlement Offer, Jusheng Bolang's interest in the Company's shares was reduced to less than 10%, therefore in accordance with the Subscription Agreement between the Company and Jusheng Bolang, they were no longer entitled to shareholder representation.